Pediatric NewsUstekinumab becomes second biologic approved for PsA in kidsAugust 3, 2022Rare DiseasesMusculoskeletal Disorders
Pediatric NewsUveitis in juvenile arthritis patients persists into midlifeJuly 13, 2022Musculoskeletal Disorders
Pediatric NewsNo more ‘escape hatch’: Post Roe, new worries about meds linked to birth defectsJune 29, 2022DermatologyGastroenterologyMusculoskeletal Disorders
Pediatric NewsBiomarkers may help to predict persistent oligoarticular JIAJune 17, 2022Rare DiseasesMusculoskeletal Disorders
Pediatric NewsFDA expands indication for spinal muscular atrophy drugMay 31, 2022Rare DiseasesNeurologyMusculoskeletal Disorders
Pediatric NewsPfizer COVID vaccine performs well in youth with rheumatic diseasesMay 17, 2022COVID-19 UpdatesVaccinesMusculoskeletal Disorders
Pediatric NewsMyositis guidelines aim to standardize adult and pediatric careMay 13, 2022Musculoskeletal DisordersRare DiseasesNeurologyOncologyGastroenterologyDermatologyPulmonology
Pediatric NewsPrior authorizations delay TNF inhibitors for children with JIAMay 11, 2022Musculoskeletal DisordersRare Diseases
Pediatric NewsChildren with RMDs not at high risk for severe COVID-19, study findsApril 13, 2022COVID-19 UpdatesMusculoskeletal DisordersInfectious Diseases
Pediatric NewsJIA disease activity, disability linked to social factorsApril 7, 2022Rare DiseasesMusculoskeletal Disorders
Pediatric NewsVirtual and in-person pediatric visits get similar family ratingsMarch 29, 2022Business of MedicineMusculoskeletal Disorders
Pediatric NewsNew JIA guidelines emphasize earlier DMARD useMarch 15, 2022Rare DiseasesMusculoskeletal Disorders
Pediatric NewsEighteen-year study shows inconsistencies in treating, classifying JIAFebruary 15, 2022Musculoskeletal DisordersAdolescent Medicine
Pediatric NewsCDC, AAP issues new guidelines to better define developmental milestonesFebruary 14, 2022NeurologyMusculoskeletal Disorders
